Notice: This company has been marked as potentially delisted and may not be actively trading. Freeline Therapeutics (FRLN) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Freeline to Present New Data on its Gaucher and Parkinson's Disease Programs at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual MeetingApril 24, 2024 | globenewswire.comFreeline Therapeutics Stock (NASDAQ:FRLN) Dividends: History, Yield and DatesFebruary 25, 2024 | benzinga.comAcquisition of Freeline by Syncona Becomes EffectiveFebruary 20, 2024 | finance.yahoo.comAcquisition of Freeline by Syncona Becomes EffectiveFebruary 20, 2024 | globenewswire.comTrading was temporarily halted for "FRLN" at 07:02 PM with a stated reason of "News pending."February 19, 2024 | marketbeat.comFreeline Therapeutics Shareholders Approve Acquisition by SynconaFebruary 13, 2024 | finanznachrichten.deFreeline Shareholders Approve Acquisition by SynconaFebruary 12, 2024 | finance.yahoo.comFreeline Therapeutics Holdings plc (FRLN)February 9, 2024 | uk.finance.yahoo.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SRC, EAR, PATI, FRLNDecember 1, 2023 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Argenx Se (ARGX) and Freeline Therapeutics Holdings (FRLN)November 30, 2023 | markets.businessinsider.comFREELINE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Freeline ...November 29, 2023 | businesswire.comFreeline (FRLN) Shares Rise on Merger Agreement With SynconaNovember 23, 2023 | finance.yahoo.comSyncona Limited to Acquire Freeline TherapeuticsNovember 22, 2023 | finanznachrichten.deFRLN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Freeline Therapeutics Holdings plc Is Fair to ShareholdersNovember 22, 2023 | tmcnet.comTrading was temporarily halted for "FRLN" at 07:11 AM with a stated reason of "News pending."November 22, 2023 | marketbeat.comFRLN Freeline Therapeutics Holdings plcNovember 18, 2023 | seekingalpha.comTrading was temporarily halted for "FRLN" at 10:11 AM with a stated reason of "LULD pause." Trading set to resume at 10:11 AM. November 6, 2023 | marketbeat.comFreeline Therapeutics Holdings PLC ADR FRLNNovember 5, 2023 | morningstar.comFreeline Therapeutics: Promising Initial Efficacy Data and Potential for High Revenues Justify Buy RatingOctober 28, 2023 | markets.businessinsider.comFreeline Presents Positive New Data from Phase 1/2 GALILEO-1 Trial of FLT201, Its Novel Gene Therapy Candidate, in Gaucher Disease at ESGCT 30th Annual CongressOctober 25, 2023 | finance.yahoo.comHere's Why We're A Bit Worried About Freeline Therapeutics Holdings' (NASDAQ:FRLN) Cash Burn SituationOctober 19, 2023 | finance.yahoo.comWhere Freeline Therapeutics Stands With AnalystsOctober 18, 2023 | markets.businessinsider.comFreeline to Present New Clinical Data for FLT201 in Gaucher Disease in Oral Presentation at Upcoming ESGCT 30th Annual CongressOctober 16, 2023 | finance.yahoo.comFreeline Therapeutics ADRs Rise 14% Following Positive Trial Data on FLT201October 6, 2023 | marketwatch.comPromising Gaucher Disease Trial Results and Potential Parkinson’s Disease Impact Bolster Analyst’s Buy Rating for Freeline Therapeutics HoldingsOctober 5, 2023 | markets.businessinsider.comWhy Is Gene Therapy Player Freeline Therapeutics Stock Trading Higher Today?October 4, 2023 | benzinga.comFreeline Reports Positive Data From First Cohort Of Phase 1/2 GALILEO-1 Trial Of FLT201October 4, 2023 | markets.businessinsider.comFreeline Reports Positive Initial Clinical Data from First Cohort of Phase 1/2 GALILEO-1 Trial of FLT201, Its Novel Gene Therapy Candidate, in Gaucher DiseaseOctober 4, 2023 | finance.yahoo.comH.C. Wainwright Sticks to Their Buy Rating for Freeline Therapeutics Holdings (FRLN)August 17, 2023 | markets.businessinsider.comFreeline Therapeutics Holdings plc (NASDAQ:FRLN) Q2 2023 Earnings Call TranscriptAugust 17, 2023 | finance.yahoo.com4 Analysts Have This to Say About Freeline TherapeuticsAugust 16, 2023 | markets.businessinsider.comQ2 2023 Freeline Therapeutics Holdings PLC Earnings CallAugust 16, 2023 | finance.yahoo.comFreeline Therapeutics GAAP EPS of -$0.23 beats by $3.28, revenue of $0.62MAugust 15, 2023 | seekingalpha.comFreeline Therapeutics Holdings plc: Freeline Reports Second Quarter 2023 Financial Results and Business HighlightsAugust 15, 2023 | finanznachrichten.deFreeline Reports Second Quarter 2023 Financial Results and Business HighlightsAugust 15, 2023 | finance.yahoo.comFreeline Therapeutics's Earnings: A PreviewAugust 14, 2023 | benzinga.comFreeline Therapeutics to Host Second Quarter 2023 Financial Results CallAugust 8, 2023 | finance.yahoo.comFreeline to Host Virtual KOL Event on its Gene Therapy Candidate, FLT201, in Gaucher DiseaseJuly 25, 2023 | finance.yahoo.comFreeline Therapeutics Holdings plcJuly 20, 2023 | thestreet.comTrading was temporarily halted for "FRLN" at 02:07 PM with a stated reason of "LULD pause." Trading set to resume at 02:07 PM. July 14, 2023 | marketbeat.comFreeline Therapeutics Holdings Shares Halted On Circuit Breaker To The Upside, Up 53.1%July 13, 2023 | benzinga.comEstimating The Fair Value Of Freeline Therapeutics Holdings plc (NASDAQ:FRLN)July 13, 2023 | finance.yahoo.comTrading was temporarily halted for "FRLN" at 10:07 AM with a stated reason of "LULD pause."July 12, 2023 | marketbeat.comTrading was temporarily halted for "FRLN" at 10:07 AM with a stated reason of "LULD pause."July 12, 2023 | marketbeat.comTrading was temporarily halted for "FRLN" at 10:07 AM with a stated reason of "LULD pause."July 12, 2023 | marketbeat.comTrading was temporarily halted for "FRLN" at 10:07 AM with a stated reason of "LULD pause." Trading set to resume at 10:07 AM. July 12, 2023 | marketbeat.comTrading was temporarily halted for "FRLN" at 09:07 AM with a stated reason of "LULD pause."July 12, 2023 | marketbeat.comTrading was temporarily halted for "FRLN" at 09:07 AM with a stated reason of "LULD pause."July 12, 2023 | marketbeat.comFreeline Announces First Patient Dosed with Its NovelJune 26, 2023 | tmcnet.comFreeline Announces First Patient Dosed with Its Novel Gene Therapy Candidate for Gaucher Disease and Unveils Research Program in GBA1-linked Parkinson’s DiseaseJune 26, 2023 | finance.yahoo.com Get Freeline Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for FRLN and its competitors with MarketBeat's FREE daily newsletter. Email Address JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback. Get your free guide NOW before it's too late. FRLN Media Mentions By Week FRLN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FRLN News Sentiment▼0.000.47▲Average Medical News Sentiment FRLN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FRLN Articles This Week▼00▲FRLN Articles Average Week Get Freeline Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for FRLN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies LianBio News PHAXIAM Therapeutics News Alpha Tau Medical News BriaCell Therapeutics News eFFECTOR Therapeutics News Fortress Biotech News GeoVax Labs News Sangamo Therapeutics News MeiraGTx News Fusion Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FRLN) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Freeline Therapeutics Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Freeline Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
